Literature DB >> 8269618

Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells.

G O Kisen1, L Tessitore, P Costelli, P B Gordon, P E Schwarze, F M Baccino, P O Seglen.   

Abstract

Autophagy, measured as the sequestration of an endogenous cytosolic enzyme (LDH), showed a progressive rate reduction during diethylnitrosamine-induced rat liver carcinogenesis. In primary hepatocellular carcinomas the autophagic activity was only one-fourth of that seen in normal hepatocytes. Reduced autophagy was also observed in peritumorous hepatocytes and in cells from preneoplastic liver, and a complete suppression of autophagic protein degradation was seen in normal hepatocytes treated with ascitic fluid from an ascites hepatoma, suggesting that tumour cells and their precursors may produce autophagy-suppressive factors with an autocrine and paracrine action. In cells from the transplantable rat ascites hepatoma, Yoshida AH-130, autophagic activity was negligible during active (logarithmic) growth, but increased to approximately 0.4%/h at high cell density, i.e. in stationary phase. In contrast to normal hepatocytes, autophagy in the AH-130 cells was not inhibited by ascitic fluid. The hepatoma cells would thus appear to have lost some aspects of autophagy regulation while retaining others. However, even the highest rate of hepatoma cell autophagy was only one-tenth of the maximal activity seen in normal hepatocytes, confirming the hypothesis that reduced autophagy may be an important aspect of growth deregulation in liver cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8269618     DOI: 10.1093/carcin/14.12.2501

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  33 in total

Review 1.  Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury.

Authors:  David H Perlmutter
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  NAD+ treatment induces delayed autophagy in Neuro2a cells partially by increasing oxidative stress.

Authors:  Jin Han; Shengtao Shi; Lan Min; Teresa Wu; Weiliang Xia; Weihai Ying
Journal:  Neurochem Res       Date:  2011-08-11       Impact factor: 3.996

3.  Membranous complexes characteristic of melanocytes derived from patients with Hermansky-Pudlak syndrome type 1 are macroautophagosomal entities of the lysosomal compartment.

Authors:  Justin W Smith; Amy Koshoffer; Randal E Morris; Raymond E Boissy
Journal:  Pigment Cell Res       Date:  2005-12

Review 4.  Therapeutic targeting of autophagy in disease: biology and pharmacology.

Authors:  Yan Cheng; Xingcong Ren; William N Hait; Jin-Ming Yang
Journal:  Pharmacol Rev       Date:  2013-08-13       Impact factor: 25.468

Review 5.  Liver autophagy: much more than just taking out the trash.

Authors:  Jaime L Schneider; Ana Maria Cuervo
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-11-05       Impact factor: 46.802

Review 6.  Autophagic proteolysis: control and specificity.

Authors:  E F Blommaart; J J Luiken; A J Meijer
Journal:  Histochem J       Date:  1997-05

7.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor.

Authors:  Zhenyu Yue; Shengkan Jin; Chingwen Yang; Arnold J Levine; Nathaniel Heintz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

8.  Disruption of lysosome function promotes tumor growth and metastasis in Drosophila.

Authors:  Congwu Chi; Huanhu Zhu; Min Han; Yuan Zhuang; Xiaohui Wu; Tian Xu
Journal:  J Biol Chem       Date:  2010-04-25       Impact factor: 5.157

Review 9.  Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes.

Authors:  Sook-Jeong Lee; Jae-Young Koh
Journal:  Mol Brain       Date:  2010-10-26       Impact factor: 4.041

Review 10.  Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer.

Authors:  Eric E Essick; Flora Sam
Journal:  Oxid Med Cell Longev       Date:  2010 May-Jun       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.